← Leaderboards
Paul Latta
Converge Biotech, Inc.
$897,913
Attributed
$897,913
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450.3K · FY2011–12$500K$375K$250K$125K$0
'11
'12
Funding mix
By agency
NIH$897,913 · 1
By mechanism
R43$897,913 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Allograft Rejection”
- Peter Scott Heeger · Case Western Reserve University$54,367,619
- Joren C Madsen · Massachusetts General Hospital$51,269,855
- Mohamed H Sayegh · University Of Pennsylvania$36,675,927
- David Michael Briscoe · Children'S Hospital Boston$26,258,786
- Allan D. Kirk · Emory University$25,949,808
- Robert Fairchild · Cleveland Clinic Lerner Com-Cwru$25,301,984
Research focus
Allograft RejectionAnimal ModelArtificial PancreasAutoimmune DiseasesAutoimmunityBaseBeliefBeta CellBiocompatible MaterialsBiologicalBlood Glucose RegulationBypassCellsCell TransplantsClinicClinical TrialsCollaborationsDesignDevicesDiabetes MellitusDiabeticDiabetic PatientDigestive System DisordersAllogenic